+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Hemostat Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Topical Hemostat Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Topical Hemostat Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989882
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Topical Hemostat Market grew from USD 2.26 billion in 2024 to USD 2.41 billion in 2025. It is expected to continue growing at a CAGR of 6.85%, reaching USD 3.36 billion by 2030.

Setting the Stage for Topical Hemostat Advancements

Advancements in surgical techniques and a heightened emphasis on patient safety have propelled the topical hemostat market into a pivotal role within modern healthcare. As procedures become less invasive and recovery expectations accelerate, the demand for reliable, easy-to-apply clotting agents has surged. This executive summary distills the critical factors shaping this dynamic landscape, offering decision-makers a concise yet comprehensive overview.

The evolution of topical hemostats reflects broader trends in precision medicine and minimally invasive surgery. Manufacturers innovate across material science and delivery formats to address diverse surgical needs, while regulatory agencies refine approval pathways to ensure safety and efficacy. In this context, understanding the interplay between product innovation, clinical adoption, and external influences such as policy changes becomes essential for stakeholders seeking to maintain competitive positioning and drive value in patient outcomes.

Emerging Forces Reshaping the Topical Hemostat Landscape

The topical hemostat landscape is undergoing a profound transformation driven by technological breakthroughs and shifting clinical paradigms. Bioengineered collagen matrices now demonstrate enhanced hemostatic performance and tissue integration, while next-generation cyanoacrylate formulations offer rapid polymerization with minimal thermal damage. Simultaneously, novel gelatin and thrombin combinations have gained traction, responding to surgeon preferences for customizable adhesion and clotting profiles.

Beyond product innovation, the convergence of digital health and surgical robotics is redefining procedural workflows. Integrated imaging and real-time analytics enable precise hemostat deployment, reducing operative time and enhancing patient safety. Strategic partnerships between device manufacturers and software developers have accelerated these advances, fueling broader acceptance among leading hospital systems. As data accrues on cost-effectiveness and clinical outcomes, payers and providers alike are redefining procurement criteria to reward solutions that deliver both economic and therapeutic value.

Assessing the Cumulative Impact of 2025 United States Tariffs

In 2025, the United States implemented a series of tariffs targeting key raw materials and finished medical products, altering the cost structure for topical hemostat suppliers and end users alike. Manufacturers reliant on imported collagen and oxidized cellulose have absorbed direct cost increases, prompting several to renegotiate supplier contracts or accelerate local sourcing initiatives. These shifts have created a ripple effect across the supply chain, compressing margins and stimulating innovation in alternative substrates.

Hospitals and ambulatory surgery centers have adjusted purchasing strategies in response. Group purchasing organizations leveraged volume commitments to secure more favorable terms, while some specialty centers explored direct‐to‐manufacturer models to bypass middle‐man markups. Despite short-term price inflation, these adaptations have accelerated the adoption of cost-containment technologies and fostered transparency in pricing agreements. Looking ahead, stakeholders who proactively address tariff-induced volatility will gain enduring resilience against future trade disruptions.

Unveiling Core Market Segments Driving Growth

A comprehensive understanding of market segmentation provides clarity on demand drivers across diverse surgical contexts. Based on product type the market encompasses collagen, cyanoacrylate, gelatin, oxidized regenerated cellulose-which itself is delivered as both fabric and powder-and thrombin. Each product category aligns with specific procedural requirements, balancing factors such as adhesion strength and ease of application.

Evaluating application segments reveals cardiovascular surgery requirements for hemostatic agents in both bypass and valve procedures, while dental surgery demands reliable performance during extraction and restorative interventions. General surgery practitioners choose between laparoscopic and open approaches, guided by agent viscosity and delivery mechanism. Neurosurgeons differentiate agent selection between adult and pediatric scenarios, and orthopedic specialists tailor usage for joint replacement versus spine procedures.

End users further refine market dynamics, with ambulatory surgery centers opting for multi-specialty or orthopedic-focused products. Clinics prioritize dental and dermatology formulations, while hospitals classify demand between private and public institutions. Specialty centers-particularly in cardiac and neurology fields-require agents with rapid onset and minimal tissue reaction.

Distribution channels underpin these interactions through field sales and tele-sales direct engagements, local and national distributor networks, inpatient and outpatient hospital pharmacies, and online platforms spanning institutional websites and third-party marketplaces. Understanding these interlocking segments enables targeted strategies that resonate with stakeholder needs at every level of the supply chain.

Decoding Regional Dynamics Across Key Geographies

Regional variations in clinical practice, healthcare infrastructure, and regulatory environments heavily influence the topical hemostat market. In the Americas, robust hospital systems and high procedural volumes drive demand for advanced formulations, while cost-containment pressures spur interest in hybrid delivery devices that optimize dosage efficiency. The presence of leading surgical device companies ensures rapid commercialization of next-generation agents.

Within Europe, Middle East & Africa, heterogeneous reimbursement models shape adoption rates. Western European nations emphasize comparative effectiveness research, favoring products with demonstrated outcome improvements. Emerging economies in the Middle East and Africa present greenfield opportunities as healthcare modernization accelerates, creating demand for user-friendly hemostats that require minimal cold chain logistics.

Asia-Pacific exhibits a dual dynamic of sophisticated urban healthcare centers and expanding rural access initiatives. High-end hospitals in major metropolitan areas lead adoption of premium collagen and cyanoacrylate products, whereas government-led programs in developing markets prioritize cost-effective agents compatible with basic surgical facilities. Strategic alliances with regional distributors accelerate market penetration and align product portfolios with local clinical protocols.

Profiling Leading Innovators and Strategic Collaborators

The competitive landscape features global corporations and agile innovators collaborating to redefine hemostatic technology. Leading multinational manufacturers leverage extensive R&D pipelines to introduce bioinspired matrices and peptide-enhanced thrombins, while mid-tier players target niche applications with specialized formulations. Joint ventures between device makers and academic institutions have spawned disruptive prototypes, such as thermoresponsive gelatin systems and smart polymers that respond to pH changes.

Strategic mergers and acquisitions have consolidated market share, enabling scale efficiencies and broader geographic reach. Some key players have integrated digital tracking within packaging to support supply chain visibility and cold chain integrity. At the same time, venture capital-backed startups are securing patents for novel delivery mechanisms, attracting partnership interest from established brands seeking growth via open innovation. This interplay of scale and nimbleness sets the stage for continuous technological renewal and competitive differentiation.

Strategic Actions to Secure Competitive Advantage

To thrive in this evolving environment, industry leaders should adopt a multi-pronged strategy that aligns product innovation with operational excellence. Prioritizing modular delivery platforms capable of accommodating multiple active agents will support broader clinical adoption and differentiate offerings. Simultaneously, investing in digital tools that enable real-time feedback on agent performance can inform iterative improvements and strengthen clinical partnerships.

On the supply side, diversifying raw material sourcing-through regional suppliers and biomanufacturing collaborations-will mitigate exposure to trade disruptions and regulatory shifts. Engaging with collaborative research consortia can accelerate formulation refinements and facilitate early access programs in targeted markets. Furthermore, establishing value-based contracting models with payers will underscore product efficacy and foster shared risk-reward frameworks, positioning companies as strategic allies in cost-effective patient care.

Rigorous Research Protocol Underpinning the Analysis

This analysis is grounded in a multi-tiered research methodology combining qualitative and quantitative techniques. Primary interviews with surgeons, procurement officers, and R&D leaders provided firsthand perspectives on clinical utilization patterns and unmet needs. Secondary research drew from regulatory filings, peer-reviewed journals, and industry databases to map historical trends and technological trajectories.

Market segmentation was validated through triangulation of company reports, distributor data, and public financial statements, ensuring accuracy in product categorization and distribution channel assessment. Region-specific insights drew upon field studies in key metropolitan centers and structured surveys among healthcare providers. Trade impact analysis leveraged customs data and tariff schedules to quantify input cost changes and trace their downstream effects. Rigorous data cleaning and cross-validation processes underpinned the integrity of all findings.

Synthesizing Insights to Inform Decision Making

The topical hemostat market stands at a nexus of innovation, regulation, and clinical demand. Technological breakthroughs in biomaterials and digital integration have unlocked new applications, while trade policy shifts and regional healthcare dynamics introduce both challenges and opportunities. Stakeholders who align strategic investments with deep segmentation insights will drive value creation and sustainable growth.

By synthesizing these insights, decision-makers can refine product portfolios, engage high-value channels, and foster collaborative relationships with payers and providers. The future will reward organizations that maintain agility in sourcing, remain proactive in clinical education, and embrace value-based contracting. Ultimately, success in this sector hinges upon the ability to translate advanced science into tangible patient benefits and operational efficiencies.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Collagen
    • Cyanoacrylate
    • Gelatin
    • Oxidized Regenerated Cellulose
      • Fabric
      • Powder
    • Thrombin
  • Application
    • Cardiovascular Surgery
      • Bypass
      • Valve
    • Dental Surgery
      • Extraction
      • Restorative
    • General Surgery
      • Laparoscopic
      • Open
    • Neurosurgery
      • Adult
      • Pediatric
    • Orthopedic Surgery
      • Joint Replacement
      • Spine
  • End User
    • Ambulatory Surgery Centers
      • Multi-Specialty
      • Orthopedic
    • Clinics
      • Dental
      • Dermatology
    • Hospitals
      • Private
      • Public
    • Specialty Centers
      • Cardiac
      • Neurology
  • Distribution Channel
    • Direct Sales
      • Field Sales
      • Tele-Sales
    • Distributors
      • Local Distributors
      • National Distributors
    • Hospital Pharmacies
      • Inpatient Pharmacies
      • Outpatient Pharmacies
    • Online
      • Institutional Websites
      • Third Party Marketplaces
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Johnson & Johnson
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Medtronic plc
  • 3M Company
  • Takeda Pharmaceutical Company Limited
  • Grifols, S.A.
  • CryoLife, Inc.
  • Integra LifeSciences Holdings Corporation
  • Terumo Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Topical Hemostat Market, by Product Type
8.1. Introduction
8.2. Collagen
8.3. Cyanoacrylate
8.4. Gelatin
8.5. Oxidized Regenerated Cellulose
8.5.1. Fabric
8.5.2. Powder
8.6. Thrombin
9. Topical Hemostat Market, by Application
9.1. Introduction
9.2. Cardiovascular Surgery
9.2.1. Bypass
9.2.2. Valve
9.3. Dental Surgery
9.3.1. Extraction
9.3.2. Restorative
9.4. General Surgery
9.4.1. Laparoscopic
9.4.2. Open
9.5. Neurosurgery
9.5.1. Adult
9.5.2. Pediatric
9.6. Orthopedic Surgery
9.6.1. Joint Replacement
9.6.2. Spine
10. Topical Hemostat Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.2.1. Multi-Specialty
10.2.2. Orthopedic
10.3. Clinics
10.3.1. Dental
10.3.2. Dermatology
10.4. Hospitals
10.4.1. Private
10.4.2. Public
10.5. Specialty Centers
10.5.1. Cardiac
10.5.2. Neurology
11. Topical Hemostat Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.2.1. Field Sales
11.2.2. Tele-Sales
11.3. Distributors
11.3.1. Local Distributors
11.3.2. National Distributors
11.4. Hospital Pharmacies
11.4.1. Inpatient Pharmacies
11.4.2. Outpatient Pharmacies
11.5. Online
11.5.1. Institutional Websites
11.5.2. Third Party Marketplaces
12. Americas Topical Hemostat Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Topical Hemostat Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Topical Hemostat Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Baxter International Inc.
15.3.3. B. Braun Melsungen AG
15.3.4. Medtronic plc
15.3.5. 3M Company
15.3.6. Takeda Pharmaceutical Company Limited
15.3.7. Grifols, S.A.
15.3.8. CryoLife, Inc.
15.3.9. Integra LifeSciences Holdings Corporation
15.3.10. Terumo Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. TOPICAL HEMOSTAT MARKET MULTI-CURRENCY
FIGURE 2. TOPICAL HEMOSTAT MARKET MULTI-LANGUAGE
FIGURE 3. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CYANOACRYLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FABRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY BYPASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY RESTORATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OPEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MULTI-SPECIALTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FIELD SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY TELE-SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY INPATIENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OUTPATIENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY INSTITUTIONAL WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 108. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 110. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 112. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 113. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 114. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 115. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 116. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 118. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 119. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 121. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 123. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 124. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 125. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 130. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 131. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 132. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 133. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 134. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 141. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 143. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 217. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 219. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 221. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 222. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 223. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 224. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 225. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 227. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 228. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 230. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 232. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 233. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 234. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 235. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 237. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 239. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 240. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 241. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 242. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 243. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 245. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 246. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 247. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 248. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 250. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 251. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 252. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 271. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 273. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 275. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 276. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 277. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 278. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 279. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 281. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 282. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 283. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 284. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 286. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 287. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 288. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 289. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 291. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 293. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 294. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 295. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 296. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 297. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 299. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 300. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 302. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 304. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 305. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 306. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 330. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 332. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 336. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 338. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 340. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 342. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 343. SOUTH AFRICA TO

Companies Mentioned

The companies profiled in this Topical Hemostat market report include:
  • Johnson & Johnson
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Medtronic plc
  • 3M Company
  • Takeda Pharmaceutical Company Limited
  • Grifols, S.A.
  • CryoLife, Inc.
  • Integra LifeSciences Holdings Corporation
  • Terumo Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.41 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.36 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Topical Hemostat Market Size, Share & Trends Analysis Report By Type (Thrombin, Collagen, Gelatin), By Application (General Surgery, Cardiovascular Surgery), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Topical Hemostat Market Size, Share & Trends Analysis Report By Type (Thrombin, Collagen, Gelatin), By Application (General Surgery, Cardiovascular Surgery), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 170 Pages
  • Global
From
Hemostats Market, By Type, By Formulation, By Application, By End User, By Distribution Channel: By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032 - Product Image

Hemostats Market, By Type, By Formulation, By Application, By End User, By Distribution Channel: By Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024-2032

  • Report
  • 277 Pages
  • Global
From
Hemostats and Tissue Sealants - Global Strategic Business Report - Product Image

Hemostats and Tissue Sealants - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Hemostats Market Report 2025 - Product Image

Hemostats Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - Product Image

Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

  • Report
  • Global
From

About the Topical Hemostat Market

In the field of wound care, the Topical Hemostat market encompasses a range of products designed to promote hemostasis, which is the process of blood clot formation to stop bleeding. These products are particularly crucial in surgical procedures, trauma situations, and in treating individuals with clotting deficiencies. Topical hemostats are available in various forms, including granular powders, films, pads, and gels. They work by different mechanisms; some provide a physical barrier to bleeding, while others promote the aggregation of platelets or catalyze the clotting process through biological or synthetic materials. The choice of topical hemostat may depend on factors such as the nature and location of the wound, the extent of bleeding, and any underlying patient conditions. With ongoing research and development, the market has seen the introduction of more advanced hemostatic agents that offer improved efficacy, faster action, and greater biocompatibility. Several companies are prominent in the Topical Hemostat market, maintaining a strong presence in the wound care sector. Notable players include Johnson & Johnson (with its ETHICON subsidiary), Baxter International Inc., Becton, Dickinson and Company (BD), CryoLife Inc., Pfizer Inc., and Z-Medica, LLC. These companies engage in the development, manufacturing, and distribution of hemostatic products, and often invest in research to advance the field of topical hemostasis further. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.